help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 31, No. 4 376-381
doi:10.1210/jcem-31-4-376
Copyright © 1970 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WALLACH, E. E.
Right arrow Articles by GARCIA, C.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WALLACH, E. E.
Right arrow Articles by GARCIA, C.-R.

Serum Gonadotropin Responses to Estrogen and Progestogen in Recently Castrated Human Females

EDWARD E. WALLACH1, ALLEN W. ROOT2 and CELSO-RAMON GARCIA

The Department of Obstetrics and Gynecology
Department of Pediatrics, School of Medicine, University of Pennsylvania
Division of Endocrinology, Children's Hospital of Philadelphia

Serum FSH and LH levels were studied in 3 females recently oophorectomized while in the reproductive age and the responses of FSH and LH levels to exogenous estrogen (mestranol, 0.1 mg) and progestogen (ethynodiol diacetate, 2.0 mg) administered separately and in combination were investigated. Medication was withheld until the 41st to 53rd postoperative days. Mestranol was then given daily for 14 days and stopped; after 14 unmedicated days ethynodiol diacetate was administered for 14 days; after a 2nd 14-day hiatus, both drugs were given for 14 days. Bloods were drawn preoperatively and immediately postoperatively, on alternate days during the first or second week before receiving mestranol, on alternate days during the week preceding each other treatment, and 3 times a week during each medicated interval. LH and FSH were measured by a double antibody radioimmunoassay. FSH and LH rose promptly in 2 subjects the first week after surgery and rose in all 3 patients over the ensuing 5 weeks. During estrogen administration, FSH levels declined and LH initially declined and then increased. With the progestogen no consistent change was seen in LH or FSH. With estrogen and progestogen administered in combination, FSH fell gradually and LH declined progressively.

Supported by USPHS Grants HD 00371, HD 00379 and TO 1 AM 05197.

1 Josiah Macy Jr. Foundation Fellow in Obstetrics and Gynecology.

2 Recipient of Career Development Award 1 KO3 HD 38338 during these studies.

Received October 13, 1969.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
I. E. Messinis
Ovarian feedback, mechanism of action and possible clinical implications
Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hestiantoro and D. F. Swaab
Changes in Estrogen Receptor-{alpha} and -{beta} in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1912 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Christin-Maitre, C. Laveille, J. Collette, N. Brion, and J.-Y. Reginster
Pharmacodynamics of Follicle Stimulating Hormone (FSH) in Postmenopausal Women during Pulsed Estrogen Therapy: Evidence That FSH Release and Synthesis Are Controlled by Distinct Pathways
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5405 - 5413.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. W. Abel, M. L. Voytko, and N. E. Rance
The Effects of Hormone Replacement Therapy on Hypothalamic Neuropeptide Gene Expression in a Primate Model of Menopause
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2111 - 2118.
[Abstract] [Full Text]


Home page
Arch Pediatr Adolesc MedHome page
E. O. Reiter, R. C. Stern, and A. W. Root
The Reproductive Endocrine System in Cystic Fibrosis: I. Basal Gonadotropin and Sex Steroid Levels
Arch Pediatr Adolesc Med, May 1, 1981; 135(5): 422 - 426.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1970 by The Endocrine Society